Avrobio, inc. (AVRO)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Cash flows from operating activities:
Net loss

-81,835

-72,965

-66,324

-60,770

-55,222

-46,361

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense

943

850

789

704

549

380

0

0

0

Stock-based compensation expense

8,167

6,800

5,994

4,748

3,542

2,196

0

0

0

Amortization of deferred offering costs

-

-

-

-

-

37

0

0

0

Impairment loss of property and equipment

-

-

-

-

-

235

0

0

0

Deferred rent expense

-185

-172

-165

-163

-137

-105

0

0

0

Change in fair value of preferred stock warrant liability

-

-

-

-

-

162

0

0

0

Change in fair value of derivative liability

-

-

-

-

-

-1,629

0

0

0

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

2,427

4,888

5,515

6,390

4,333

3,037

0

0

0

Other assets

0

-

-

-

-

115

0

0

0

Accounts payable

-1,086

1,028

62

-985

1,251

2,018

0

0

0

Accrued expenses and other current liabilities

3,981

1,920

4,381

3,591

3,535

5,313

0

0

0

Net cash used in operating activities

-72,364

-67,668

-60,519

-59,122

-49,406

-37,648

0

0

0

Cash flows from investing activities:
Purchases of property and equipment

1,822

1,585

1,312

2,149

1,909

1,832

0

0

0

Net cash used in investing activities

-1,822

-1,585

-1,053

-2,173

-1,909

-1,832

0

0

0

Cash flows from financing activities:
Proceeds from exercise of stock options

285

502

0

0

0

-

-

-

-

Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs

-

-

-

-

-

58,257

0

0

0

Proceeds from issuance of common shares upon completion of public offering, net of offering costs

0

-

-

-

-

-

-

-

-

Payments of initial public offering costs

-

-

-

-

-

-

-

-

0

Net cash provided by financing activities

223,405

129,994

129,825

-2,904

102,331

160,287

0

0

0

Net increase (decrease) in cash, cash equivalents and restricted cash

149,219

60,741

68,253

-64,199

51,016

120,807

0

0

0

Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable and accrued expenses

-

-

-

-

-

256

0

0

0

Property and equipment held for sale

-

-

-

-

336

19

0

0

0

Offering costs included in accrued expenses and accounts payable

0

-

-

-

-

-

-

-

-

Deferred offering costs included in accrued expenses

-

-

-

-

-

-

-

0

0

Purchase of property and equipment paid for by landlord

-

-

-

-

-

842

0

0

0

Accretion of issuance costs related to redeemable convertible preferred stock

-

-

-

-

-

2,243

0

0

0